Hogehilweg 18 Mon-Fri 08:30-17:30
MijnMedicijn
📞 Contact phone — free, 24/7

Order Coumadin safely online in the Netherlands

Warfarin

★★★★☆ 4.5 (195 reviews)
In stock — ready for delivery today
Choose dosage and pack size
PackagePrice per DosePrice
360 pills€0,76
€340,49
€272,39
Free shipping
180 pills€0,83
€187,26
€149,81
120 pills€0,94
€139,97
€111,98
90 pills€1,00
€111,59
€89,27
60 pills€1,07
€81,33
€65,06
30 pills€1,17
€43,49
€34,79
360 pills€0,91
€408,60
€326,88
Free shipping
180 pills€0,98
€221,31
€177,05
120 pills€1,06
€158,89
€127,11
90 pills€1,15
€128,62
€102,90
60 pills€1,29
€96,46
€77,17
30 pills€1,48
€54,84
€43,87
360 pills€1,01
€455,89
€364,71
Free shipping
180 pills€1,20
€268,61
€214,89
Free shipping
120 pills€1,36
€204,29
€163,43
90 pills€1,51
€170,24
€136,19
60 pills€1,53
€115,38
€92,30
30 pills€1,62
€60,52
€48,41
20 pills€1,71
€43,49
€34,79
10 pills€1,73
€20,79
€16,63
€272,39
Quantity:
✈️
Airmail 14–21 days
⚡
Express delivery 5–9 days
🎁
Free Airmail from €182,34
🔒
Crypto discount −10%

Disclaimer: This information is intended for patients in the Netherlands and is not a substitute for professional medical advice. Please consult a pharmacist or physician for personalized guidance.

Coumadin (warfarin): definition, drug class, and primary purpose

Coumadin (warfarin) is an oral anticoagulant belonging to the coumarin class of medications, prescribed to reduce the risk of blood clots by inhibiting clotting factor production in the liver.

In pharmacology terms (the science of how drugs act in the body), warfarin inhibits the synthesis of vitamin K–dependent clotting factors II, VII, IX, and X, as well as proteins C and S, which may extend the time required for blood to clot.

Its primary therapeutic purpose is to prevent stroke, venous thromboembolism, and other clot-related complications in patients with various conditions, while balancing the risk of bleeding.

The drug is typically used under medical supervision and requires regular monitoring of the international normalized ratio (INR) to maintain a safe therapeutic range and to adjust the dose as needed.

In the Netherlands, warfarin is often prescribed when specific indications require reliable, long‑term anticoagulation, and patients are advised about dietary consistency and monitoring routines as part of treatment planning.

Approved indications for Coumadin in the Netherlands

Warfarin is approved for prevention and treatment of thromboembolic events in several conditions, with the aim of reducing the risk of clot-related complications.

Indications commonly encountered include prevention of stroke in certain patients with atrial fibrillation or flutter, particularly when additional risk factors are present, and prevention of venous thromboembolism after surgery or during prolonged immobilization.

Warfarin is also used for the prevention of thromboembolism in patients with mechanical heart valves, where the valve design necessitates consistent anticoagulation to reduce valve‑related clot formation.

In some clinical situations, warfarin serves as long-term anticoagulation in patients with certain congenital or acquired heart or vascular conditions where other agents are not suitable or are contraindicated.

Ongoing INR monitoring and individualized dosing are integral to maintaining safe and effective anticoagulation in these indications.

Off-label and commonly practiced uses with Coumadin

Off-label and practical uses may be considered in specific clinical contexts, subject to clinician judgment and local guidelines. The information provided here focuses on commonly recognized scenarios and does not substitute professional advice.

In some patients with high thrombotic risk, warfarin may be used as part of a combined strategy with other therapies, depending on the balance of bleeding risk and clot risk, and after careful discussion with a healthcare professional.

Warfarin can be used as a bridging strategy in certain perioperative settings, where anticoagulation is temporarily altered around the time of surgery, under close medical supervision.

For individuals with complex medical histories or concomitant conditions, treatment plans may involve alternative anticoagulants or tailored regimens, with decisions guided by specialist input and local standards of care.

Resident clinicians and pharmacists may tailor monitoring frequency, dietary guidance, and documentation to reflect the patient’s specific risk factors and treatment goals.

Mechanism of action: how Coumadin prevents clot formation

At a basic level, warfarin reduces the blood’s ability to clot by interfering with the production of certain proteins that are essential for coagulation, thereby slowing down clot formation.

On a pharmacological level (study of drug interactions and effects), warfarin inhibits the enzyme vitamin K epoxide reductase, which is required to recycle vitamin K to its active form. Without sufficient active vitamin K, liver cells produce fewer functional clotting factors II, VII, IX, and X, along with proteins C and S, resulting in a reduced overall coagulation potential.

This mechanism creates a dose-dependent anticoagulant effect that can be adjusted by monitoring the INR, ensuring that clotting time is neither too low (risk of clots) nor too high (risk of bleeding).

The action of warfarin is influenced by dietary vitamin K intake, genetic factors affecting metabolism, other medications, and overall liver function, all of which can modify the rate at which anticoagulation develops or wanes.

Because the coagulation system is a cascade of sequential steps, even small changes in the activity of one factor can alter the overall clotting tendency, underscoring the need for careful dose adjustments and regular lab checks.

Pharmacokinetics and pharmacodynamics of warfarin

Pharmacokinetics describes how the drug is absorbed, distributed, metabolized, and eliminated, while pharmacodynamics describes the drug’s biochemical and physiological effects on the body.

Warfarin is well absorbed from the gastrointestinal tract and distributes widely in body tissues. Its anticoagulant effect is not immediate because existing clotting factors in circulation must be depleted before the full effect appears, which can take several days.

Metabolism occurs primarily in the liver via cytochrome P450 enzymes, with genetic and environmental factors contributing to individual variability in how quickly warfarin is cleared from the body. The elimination half-life is variable and can range from about 20 to 60 hours, depending on the individual and the specific formulation used.

Therapeutic response depends on maintaining a stable level of active warfarin in the blood. Changes in diet, other medicines, or health status can alter drug levels and the INR, necessitating dose adjustments and closer monitoring.

In the Netherlands, routine INR monitoring is integral to therapy, with clinicians adjusting dose to maintain target ranges appropriate for the indication and patient risk factors.

Dosing and INR monitoring: practical guidance for everyday use

Dosing is individualized based on the indication, INR history, concomitant medications, and dietary vitamin K intake. Regular blood tests are used to guide dose adjustments and to keep the INR within a safe range.

Initial dosing decisions are made by a clinician and are followed by frequent monitoring, especially at the start of therapy or after any change in dose, health status, or medication list.

INR targets vary by indication. For many patients with non‑valvular atrial fibrillation or venous thromboembolism, an INR of roughly 2.0–3.0 is common, while certain mechanical heart valves may require a higher target range, as determined by the treating specialist.

Dietary consistency regarding vitamin K is encouraged, as large fluctuations can affect the INR. Education on avoiding rapid, extreme changes in vitamin K intake is a standard part of therapy initiation and follow‑up.

When travelling or undergoing procedures, clinicians may provide timing notes or bridging strategies to maintain safe anticoagulation. Any planned interruption of therapy should be managed by a healthcare professional.

Safety considerations: contraindications, adverse effects, and pregnancy

Warfarin is not suitable for everyone. Absolute contraindications include active significant bleeding and certain severe bleeding disorders, among other conditions. A clinician will assess risks and benefits before starting therapy.

Major adverse effects involve bleeding or hemorrhage, which may occur in any organ system. Prompt medical attention is required for unusual or uncontrolled bleeding, persistent severe headaches, or sudden changes in mobility or alertness.

Several factors can increase bleeding risk, including concurrent antiplatelet therapy, nonsteroidal anti‑inflammatory drugs, certain antibiotics, liver disease, or very high blood pressure, among others. A healthcare professional will review all medications and health factors to minimize risk.

Pregnancy often requires special considerations because warfarin is teratogenic (capable of causing fetal malformation) and can pose risks to a developing fetus. Alternative anticoagulation strategies are typically discussed with obstetric and medical teams if pregnancy occurs or is planned.

Breastfeeding is generally considered compatible with warfarin, but the decision should be made in consultation with a clinician, considering the full clinical context and any potential drug interactions.

Food, vitamin K, and dietary considerations while using Coumadin

Vitamin K intake influences the effectiveness of warfarin. Foods rich in vitamin K, such as leafy green vegetables, can affect INR if consumed in large, sudden amounts.

Consistency is key. Rather than avoiding vitamin K entirely, it is recommended to maintain a relatively stable intake of vitamin K from day to day and to discuss any substantial dietary changes with a clinician or pharmacist before making adjustments.

Alcohol consumption should be discussed with a healthcare professional, as excessive intake can interact with warfarin and influence bleeding risk or INR stability.

Supplements and herbal products may interact with warfarin and alter anticoagulant effects. It is important to disclose all vitamins, minerals, herbal products, and specialty supplements to a healthcare professional before starting or stopping any product.

In the Netherlands, dietary guidance about vitamin K and other lifestyle factors is often included in patient education to help maintain a stable INR and reduce bleeding risk during long‑term therapy.

Drug interactions and supplements: how to minimize risk on warfarin therapy

Numerous prescription and over‑the‑counter medicines can interact with warfarin, potentially increasing or decreasing its effect. A clinician or pharmacist should review all medicines at each visit or whenever a new medicine is started.

Common interacting medications include certain antibiotics, antifungals, antifibrals, antifibrinolytics, anticonvulsants, and antiarrhythmic drugs. These interactions may require INR monitoring or dose adjustment.

Bleeding risk may increase when warfarin is used with other antiplatelet agents (for example some pain relievers or cardiovascular medications). Decisions about combination therapy should be made by a healthcare professional with careful assessment of risks and benefits.

Herbal and dietary supplements such as ginkgo, garlic, ginger, St. John’s wort, and others have potential interactions with warfarin. Disclosure of supplement use is essential for safe management.

All changes to medications or supplements should be communicated promptly to the prescribing clinician or pharmacist, who can determine whether monitoring or dose adjustments are necessary.

Storage, handling, and travel considerations for Coumadin

Warfarin tablets should be stored at room temperature, away from moisture and heat, in their original packaging to protect from light and humidity.

Keep all tablets out of reach of children and pets, and do not use medication beyond its expiration date. Any concerns about tablet integrity should be directed to a pharmacist.

During travel or changes to routine, carry a copy of the medication list and a recent INR result if available. Inform healthcare providers encountered during travel about warfarin use and any planned procedures or tests.

In cases of severe illness, prolonged vomiting or diarrhea, or major trauma, contact a healthcare professional promptly as these conditions can affect the safety and effectiveness of warfarin therapy.

Comparative overview: Coumadin versus related anticoagulants

IndicationWarfarin (Coumadin)NOACs/DOACs (e.g., rivaroxaban, apixaban, dabigatran)
Atrial fibrillation (non-valvular)Commonly used; requires INR monitoringOften used; may not require routine monitoring in some settings
Mechanical heart valvesTypically the preferred anticoagulantNot generally recommended for this indication
Venous thromboembolism (DVT/PE) treatmentYes; long-term management possibleWidely used; many patients switch to NOACs when appropriate

Practical guidance for patients taking Coumadin in the Netherlands

Regular INR testing is essential to ensure safety and effectiveness. The frequency of testing decreases as stability is achieved, but periodic checks remain important for ongoing therapy.

Dietary consistency regarding vitamin K helps maintain stable INR. Sudden changes in dietary vitamin K intake can alter the anticoagulant effect and may require dose adjustments.

Medication reconciliation is important at every visit. A pharmacist will review all medicines, supplements, and over‑the‑counter products to identify potential interactions with warfarin.

When any new health issue arises—such as infection, surgery, or bleeding—immediate medical advice should be sought. Bleeding symptoms or unusual bruising should be reported promptly to a healthcare professional.

Patients should be informed about the importance of adherence, the potential need for bridging therapy around procedures, and how to respond to missed doses or emergency situations in line with local guidelines.

Frequently asked questions about Coumadin

Introductory guidance: This section provides concise answers to common questions regarding the use of warfarin, its effects, and practical management in daily life. For personalized advice, consult a healthcare professional.

Can Coumadin work immediately after starting therapy?

No. Warfarin’s full anticoagulant effect develops over several days as existing clotting factors are depleted and new factors are produced with reduced activity. Initial protection may be incomplete, and monitoring is used to guide dosing during this period.

How long will the treatment last?

Duration is individualized and depends on the underlying condition and ongoing risk. Some patients require long‑term anticoagulation, while others may have shorter courses or planned assessments to determine the necessity of continued therapy.

Is it safe to drink alcohol while on warfarin?

Moderate, consistent alcohol intake may be permissible for many patients, but excessive consumption can affect bleeding risk and INR stability. A clinician can provide personalized recommendations based on the overall treatment plan.

Can I take aspirin or other antiplatelet medicines with Coumadin?

Bleeding risk increases with concomitant antiplatelet therapy. The decision to use both therapies should be made by a clinician who will weigh clot prevention benefits against bleeding risk and may require monitoring adjustments.

What should I do if I miss a dose?

Do not double up doses unless advised by a healthcare professional. If a dose is missed, contact a clinician or pharmacist to determine the appropriate next steps. Do not substitute without guidance.

Can I eat foods containing vitamin K while taking warfarin?

Vitamin K intake can affect anticoagulation. A consistent dietary pattern is recommended, rather than strict avoidance of vitamin K. Changes in diet should be discussed with a healthcare professional.

Is warfarin safe during pregnancy?

Warfarin is generally avoided during pregnancy due to fetal risks. Alternative anticoagulation options are discussed with obstetric and medical teams if pregnancy occurs or is planned.

Is warfarin compatible with breastfeeding?

In most cases, warfarin is considered compatible with breastfeeding, but it is advisable to review this with a clinician to confirm suitability in the specific clinical context.

How is INR monitored and what does the test involve?

INR monitoring involves a blood test performed by a qualified professional. The results guide dose adjustments to keep the INR within the target range for the individual’s condition.

Can warfarin interact with herbal supplements?

Yes, certain herbal products can interact with warfarin and influence bleeding risk or INR. Disclosure of all supplements to a clinician is essential for safe management.

What should be done before a planned medical procedure or dental work?

Inform the treating clinician about warfarin use. A plan may be required to adjust the regimen temporarily to minimize bleeding risk, under professional supervision.

✈️

Airmail

14–21 days. Free from €182,34 .

⚡

Express delivery

5–9 days. €27,35

🔒

Crypto discount

−10% when paying with cryptocurrency.

🔄

Reorder discount

−10% on all repeat orders.

📦 Packaging and discretion

All orders are packed in neutral, unbranded boxes with no product name on the outside.

Sander de Vries
Medically reviewed by
Sander de Vries
Registered Pharmacist (Apotheker)